This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Jan;154(1):153.

doi: 10.1016/j.jpeds.2008.10.028.

Escalating dose indomethacin for prophylactic closure of patent ductus arteriosus does not improve closure rates and is associated with increased complications

Timothy Cotts¹

Affiliations

PMID: 19187749
DOI: 10.1016/j.jpeds.2008.10.028

Comment

Escalating dose indomethacin for prophylactic closure of patent ductus arteriosus does not improve closure rates and is associated with increased complications

Timothy Cotts. J Pediatr. 2009 Jan.

. 2009 Jan;154(1):153.

doi: 10.1016/j.jpeds.2008.10.028.

Author

Timothy Cotts¹

Affiliation

¹ University of Michigan, Ann Arbor, Michigan, USA.

PMID: 19187749
DOI: 10.1016/j.jpeds.2008.10.028

No abstract available

PubMed Disclaimer

Comment on

Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial.
Jegatheesan P, Ianus V, Buchh B, Yoon G, Chorne N, Ewig A, Lin E, Fields S, Moon-Grady A, Tacy T, Milstein J, Schreiber M, Padbury J, Clyman R. Jegatheesan P, et al. J Pediatr. 2008 Aug;153(2):183-9. doi: 10.1016/j.jpeds.2008.01.031. Epub 2008 Mar 19. J Pediatr. 2008. PMID: 18534218 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources